GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Orthometrix OMRX · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2013

Revenue

$1.1m

FY2013FY2013

Net income

$63,544

FY2013FY2013

Free cash flow

$232,935

FY2013FY2013

Shareholders' equity

−$2.9m

FY2013FY2013

Income statement

Fiscal years

FY2013
Revenue$1.1m
Gross profit$744,407
Operating income$134,467
Net income$63,544
Diluted earnings per share0.00

Balance sheet

At each fiscal year end

FY2013
Total assets$295,859
Total liabilities$3.2m
Debt$630,938
Shareholders' equity−$2.9m
Shares outstanding22m

Cash flow

Fiscal years

FY2013
Cash from operations$232,935
Free cash flow$232,935

Latest quarters

By quarter end

Mar 2015Dec 2014Sept 2014Jun 2014Sept 2008Jun 2008Mar 2008Dec 2007
Revenue$124,561$147,020$395,673$236,386$130,130$226,174$363,732$736,706
Gross profit$78,111$61,141$285,415$158,743$12,593$68,156$170,917$339,389
Operating income−$156,752−$160,514$94,710−$38,031−$240,198−$179,677−$151,449$19,629
Net income−$167,282$38,228$81,963−$75,869−$309,658−$265,227−$241,299−$143,077
Diluted earnings per share-0.010.000.00-0.00-0.01-0.01-0.01-0.01
Total assets$507,055$809,809$802,040$726,109$581,839$605,472$598,903$794,136
Debt$545,119$545,119——$2.4m$2.4m$2.2m$1.9m
Shareholders' equity−$2.7m−$2.5m−$2.6m−$2.6m−$3.5m−$3.2m−$3.0m−$2.9m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-23.7%-6.7%-22.3%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin66.5%57.9%59.5%50.7%
Operating margin-0.5%2.3%-40.1%—
Net margin-9.7%-14.2%-54.0%—

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return0%0%0%0%55%836%322%-40%123%-25%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 3-for-2 split · 17 Jun 1996

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.